Rare diseases
Investigational molecules
Locations
Back to France951 clinical trials in Nantes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma
FranceStudy on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction
FranceStudy on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation
FranceStudy Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma
FranceStudy on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination
FranceStudy on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination
FranceStudy on Hydroxychloroquine and Prednisone for Patients with Non-Severe Extra-Pulmonary Sarcoidosis
FranceStudy on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis
FranceStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
FranceStudy on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
FranceStudy Comparing Clofarabine/Busulfan and Fludarabine/Busulfan for Adults with Acute Myeloid Leukemia Eligible for Stem Cell Transplantation
FranceStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on multiple myeloma, leukemia, and various lymphomas. Studies are evaluating novel treatment combinations and therapeutic approaches for blood cancers.
Innovative trials exploring combinations of targeted therapies and immunotherapies to improve patient outcomes.
Comprehensive studies on preventive measures against viral infections, including trials for vaccines targeting CMV, yellow fever, and mpox.
Focus on developing and evaluating new vaccine formulations and delivery methods.
Research investigating treatments for inflammatory bowel diseases and multiple sclerosis, including innovative approaches like fecal microbiota transplantation.
Exploring novel therapeutic options and treatment de-escalation strategies.
Studies addressing postoperative care and management of severe conditions in intensive care settings, including burns and immune suppression.
Evaluating new approaches to improve patient comfort and outcomes in critical care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
